CARGO Therapeutics Inc. Common Stock (CRGX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    CARGO Therapeutics Inc. C...

    NASDAQ: CRGX · Real-Time Price · USD
    4.47
    0.00 (0.00%)
    At close: Aug 18, 2025, 3:59 PM

    CARGO Therapeutics Common Stock Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 7.07M 3.69M 1.44M 147K
    Gross Profit
    		 -7.07M -3.69M -1.44M -147K
    Operating Income
    		 -187.37M -96.71M -34.77M -5.98M
    Interest Income
    		 20.06M n/a n/a n/a
    Pretax Income
    		 -167.5M -98.15M -40.95M -5.85M
    Net Income
    		 -167.5M -98.15M -40.95M -5.85M
    Selling & General & Admin
    		 43.97M 17.23M 5.4M 1.52M
    Research & Development
    		 143.4M 75.79M 29.37M 4.46M
    Other Expenses
    		 -7.07M n/a -1.44M -147K
    Operating Expenses
    		 180.3M 93.02M 33.33M 5.83M
    Interest Expense
    		 n/a 1.6M 4.94M n/a
    Selling & Marketing Expenses
    		 n/a -3.69M n/a n/a
    Cost & Expenses
    		 187.37M 96.71M 34.77M 5.98M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 44.97M 41.21M 19.23M 19.47M
    Shares Outstanding (Diluted)
    		 44.97M 41.21M 19.23M 19.47M
    EPS (Basic)
    		 -3.72 -2.38 -2.13 -0.3
    EPS (Diluted)
    		 -3.72 -2.38 -2.13 -0.3
    EBITDA
    		 -160.43M -93.02M -34.56M -5.7M
    EBIT
    		 -167.5M -96.54M -36.01M -5.85M
    Depreciation & Amortization
    		 7.07M 3.69M 1.44M 147K

    Add to Watchlist